دورية أكاديمية

Optimisation of an in vitro human cardiovascular model on-a-chip for toxicological assessment of nicotine delivery products.

التفاصيل البيبلوغرافية
العنوان: Optimisation of an in vitro human cardiovascular model on-a-chip for toxicological assessment of nicotine delivery products.
المؤلفون: Chapman, Fiona, de Haan, Luuk, Gijzen, Linda, Strijker, Wouter, Trelles Sticken, Edgar, Pour, Sarah Jean, Wieczorek, Roman, Haberstroh, Florian, Otte, Sandra, Nahde, Thomas, Simms, Liam, Stevenson, Matthew
المصدر: Frontiers in Toxicology; 2024, p01-16, 16p
مصطلحات موضوعية: ELECTRONIC cigarettes, NICOTINE, ENDOTHELIUM diseases, TOBACCO products, SMOKING, VASCULAR remodeling
مستخلص: Background: Smoking cigarettes is a cause of serious diseases in smokers, including cardiovascular disease. Through a pathway of endothelial dysfunction, lipid infiltration, macrophage recruitment and vascular remodeling, atherosclerosis is fundamental in the development of most cardiovascular diseases. There is an increasing number of next-generation products (NGP) which provide potentially reduced harm forms of nicotine delivery to adult smokers. This study aimed to optimise an in vitro cardiovascular model to assess such products. Human Coronary Artery Endothelial Cells (HCAECs) were cultured on an OrganoPlate® 2-lane chip (Mimetas BV) combined with THP-1 monocytes under flow conditions. Methods: An aqueous aerosol extract from the 1R6F reference cigarette was compared with two categories of NGP, (a heated tobacco product (HTP) and an electronic nicotine delivery system (ENDS)), to assess relative effects on select atherogenic endpoints (oxidative stress, monocyte adhesion, ICAM-1 expression, and inflammatory markers). Following exposure of THP-1 monocytes with the aqueous extracts, the resulting conditioned medium was then added to the HCAEC vessels. Results: 1R6F was consistently the most potent test article, eliciting observed responses at 4x lower concentrations than applied for both the HTP and ENDS. The HTP was more potent than the ENDS product across all endpoints, however, all test articles increasedmonocyte adhesion. ICAM-1 did not appear to be amain driver for monocyte adhesion, however, this could be due to replicate variability. Upon comparison to an extract-only control exposure, THP-1-medium pre-conditioning was an important mediator of the responses observed. Conclusion: In conclusion, the data suggests that the NGP extracts, containing primary aerosol chemical constituents exhibit a marked reduction in biological activity in the early key events associated with atherogenesis when compared to a cigarette, adding to the weight of evidence for the tobacco harm reduction potential of such products. [ABSTRACT FROM AUTHOR]
Copyright of Frontiers in Toxicology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:26733080
DOI:10.3389/ftox.2024.1395670